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Abstract
Because of the scarcity of megakaryocytes in hematopoietic tissues, studying megakaryopoiesis heavily relies on the
availability of appropriate cellular models. Here, we report the establishment of a new mouse embryonic stem (ES) cell-
derived megakaryocytic cell line, MKD1. The cells are factor-dependent, their cell surface immunophenotype and gene
expression profile closely resemble that of primary megakaryocyte progenitors (MkPs) and they further differentiate along
the megakaryocyte lineage upon valproic acid treatment. At a functional level, we show that ablation of SCL expression, a
transcription factor critical for MkP maturation, leads to gene expression alterations similar to that observed in primary, Scl-
excised MkPs. Moreover, the cell line is amenable to biochemical and transcriptional analyses, as we report for GpVI, a direct
target of SCL. Thus, the MKD1 cell line offers a pertinent experimental model to study the cellular and molecular
mechanisms underlying MkP biology and more broadly megakaryopoiesis.
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Introduction
The study of megakaryopoiesis has been hindered by difficulties
in obtaining large numbers of pure megakaryocytes. Although
recent technical advances allow purification of megakaryocytes
from primary hematopoietic progenitors [1–3], cell numbers
remain lowand the cultures arenot synchronous norhomogeneous.
Permanent cell lines are an alternative source of megakaryocytes
(MKs) and have proven very useful in studying megakaryocytic
differentiation (for review, see Saito [4]). So far, MK cell lines have
been mainly derived from human leukemic patients, with many
inherent shortcomings including abnormal karyotypes. Moreover,
many of these cell lines are immature and show multiphenotypic
characteristics of erythroid, myeloid and MK lineages. Very few
present with more restricted MK-specific phenotype and treat-
ment with phorbol esters often enhances their MK program [4].
Here, we report the establishment of new MK cell lines from
murine embryonic stem (mES) cells, upon expression of the
homeobox gene Hox-11, a potent immortalizing agent of bone
marrow [5] and ES cell-derived hematopoietic cells [6]. Several
growth factor-dependent clones exhibiting megakaryocytic fea-
tures and various degrees of megakaryocytic differentiation were
obtained. Clone MKD1 was extensively studied at cellular,




fl/fl and PF4-Cre mice described in [7] were housed according
to national and institutional guidelines for humane animal care.
Immortalization of mouse Scl
fl/fl ES cell-derived
hematopoietic cells with Hox11
Scl
fl/fl ES cells were obtained from neo-excised Scl
fl/wt cells
(derived from mouse E14Tg2a ES cells) [7] after a second round of
homologous recombination. Transduction of Scl
fl/fl ES cells with
Hox11 (Hox11 vectors were gifts from G. Keller), differentiation
into embryoid bodies (EBs) and establishment of immortalized
cultures have been described [6].
Antibodies and reagents
All antibodies were purchased from BD pharmingen except for
CD42b, (PE-conjugated GpIba, a kind gift from B. Nieswandt
(Germany). Valproic acid was from Sigma.
Cellular staining, ploidy, FACS analyses, real-time PCR, MkP
purification, nucleofection and Cre-mediated excision in MKD1
were as described [7].
GpVI promoter. A 330 bp sequence encompassing the Gp6
promoter (2330/+1) was PCR-amplified from mouse genomic
DNA and cloned into pGL4b (Promega). Luciferase-based
transactivation assays were performed in 3T3 and MKD1 cells
as described [7,8]. For Chip, primers and 59FAM-39TAMRA
labelled probes were selected from unique sequences in the GpVI
locus and appropriate external controls using Primer Express
Software (sequences available upon request). Input and
immunoprecipitated material were analysed in duplicates relative
to a sequence in the Gapdh locus.
Differentiation. Cells were seeded at a density of 2–4610
5
cells/ml in presence of Epo, IL-3 and valproic acid for 3 to 7
days.
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In an attempt to study the functional role of SCL/Tal1, a
master regulator of hematopoiesis (see [7] and references therein),
in ES cell-derived megakaryopoiesis, we generated Scl
flox/flox ES
cells. Importantly, using in vitro differentiation assays, we did not
observe morphological or biological differences between wild-type
and Scl
flox/flox ES cell-derived hematopoietic cells and, more
specifically MKs (data not shown), thereby establishing the
neutrality of the loxP sites introduced into the Scl locus.
Hematopoietic cell lines were then established from Scl
flox/flox ES
cells (Figure 1A). Briefly, Hox-11 transduced ES cells were in vitro
differentiated into embryoid bodies (EBs). Day 7 EBs were
dissociated and cells maintained in liquid cultures in three
different cytokine conditions (Epo/IL3, Tpo/KL, and Epo/KL).
After 6 and 8 weeks, hematopoietic cells were seeded onto
methylcellulose. Immortalized colonies were isolated 8 to 10 days
later and expanded in liquid culture in the appropriate cytokine
condition. Morphological inspection and immuno-phenotyping
identified megakaryocytic (MK) cell lines in the Epo/IL3
condition only (not shown). In agreement with this, most
Hox11-immortalized hematopoietic clones are IL3-dependent
for their growth and survival [5]. Several immortalised MK
clones showing different degrees of differentiation were obtained,
as judged by cellular staining (MGG and Acetylcholine Esterase,
AchE, a MK-specific marker) (Figure 1B) and by the percentage of
cells that (i) express CD41
+ (GpIIb) and CD42b
+ (GpIba) (two cell
surface markers expressed in differentiating MKs); (ii) are positive
for AchE; (iii) exhibit ploidies greater than 8N (Table 1). Whilst
clones C7, E7 and G10 showed relatively high levels of CD41 and
CD42b expression (ranging from 67% to 96% and 12% to 30%,
respectively) and AchE positivity (15% to 90%), clone D1 (MKD1)
showed lower CD41, CD42b and AchE expression (40%, 2.8%
and 2% respectively). Although clones E7 and G10 seemed more
advanced in their differentiation than the MKD1 clone, their
ploidy (4% of E7 and G10 cells had a ploidy greater than 8N,
compared to 3% for the MKD1 clone) and their gene expression
profile, when assayed for the MK-specific markers shown in
Figure 1F (data not shown), were similar to that of MKD1 cells.
We decided to focus on the MKD1 clone as a potential model of
early megakaryopoiesis because, similarly to MkPs and immature
MKs, MKD1 displayed low AchE activity and low ploidy [9].
Moreover, as described below, expression of CD41 and 42b
increases as MKD1 cells differentiate along the megakaryocytic
lineage, as also reported for MkPs [9].
MKD1 cells exhibited a MK-specific immunophenotype
(Figure 1 C–D). They were negative for the early stem cell marker
Sca1 (1.2%) and for markers of lymphoid (B220, CD8, Thy1, IL7-
R) and myeloid (Gr1, Mac1) lineages; although 5% of the cells
expressed Ter119 (erythroid-specific), they did not stain for
benzidine (not shown), suggesting limited erythroid potential.
They essentially expressed ckit and MK-specific markers CD41/
CD61 (40 to 50%), CD42b (2.8%), GPVI (12%) and CD9 (100%)
(Figure 1D). In order to better assign them to a specific stage in
megakaryopoiesis, we compared MKD1 cells to primary mega-
karyocyte progenitors (MkPs) as defined by Weissman et al [2]




low, but only 50 to 60% CD41
+ as opposed to
100% in MkPs.
Next, we compared the levels of expression of selected genes in
MKD1 cells, to that observed in MkPs and more mature, MkP-
derived MKs (MkPs day3) (Figure 1F). Expression of the genes
coding for the transcription factors Scl, Gata1, Nfe2 and the surface
membrane protein GpIba was similar across the cell types; Eklf was
expressed at higher levels in MKD1 than in MkPs and not
detected in mature MKs. Confirming the immature nature of
MKD1 cells, levels of late markers such as b1-tubulin (Tubb1),
Glycoprotein 9 (Gp9), von Willebrand factor (vWF) and Platelet
factor 4 (Pf4) were lower in MKD1 than MkPs; Glycoprotein 6
(Gp6) was expressed at low levels, similar to that in MkPs.
Interestingly, compared to MkPs, MKD1 cells express similar
levels of Epo receptor (EpoR), but very low levels of the
thrombopoietin (Tpo) receptor (cMpl), consistent with their EPO-
dependence. EpoR and cMPL, as well as their respective ligands,
share significant structural [10] and functional homology [11,12].
Therefore, although TPO remains the primary growth factor of
the MK lineage [13], supporting both proliferation and differen-
tiation of MkPs, Epo/EpoR-mediated signalling pathways could
substitute for those normally transmitted through Tpo/cMPL in
MKD1 cells.
It is noteworthy to point out that MKD1 cell line was derived
from day 7 EBs, a stage representative of the yolk sac phase of
hematopoiesis [14]. Interestingly, Xu et al. [15] have reported the
Table 1. Generation of MK clones showing different degrees
of differentiation.
Clones CD41 (%) CD42b (%) AchE (%) Ploidy.8N (%)
C7 67 12 15 2.2
E7 96 30 50 4.27
G 1 0 9 62 4 9 04 . 0 4
D1 40 2.8 2 3.03
doi:10.1371/journal.pone.0032981.t001
Figure 1. MKD1 cell line exhibits characteristics of primary MkPs. (A) Outline of the strategy used to isolate immortalized MK clones. (B)
(Left) MGG staining reveals small cells with a high nuclear/cytoplasmic ratio (arrow heads) and large cells with multilobulated nuclei (arrows). (Right)
AchE staining (red arrow). The photographs were taken using an Olympus BX60 microscope with a Qimaging camera (Surrey, BC). Openlab version 3
software (Improvision, Coventry, UK) was used for image acquisition and images were exported into Adobe Photoshop version CS2 (Adobe Systems,
San Jose, CA). (C–D) Analysis of MKD1 cells by flow cytometry. Cells were stained for lineage-specific markers (C) and MK-specific markers (D). The
hatched histograms represent the staining with the indicated antibody and the open histograms correspond to the isotype control. One









+.( F) Gene expression profile in MKD1 cells. Analysis by real-time RT-PCR of levels of expression of MK and
erythroid-specific markers from mRNA isolated from MKD1 (white bars), primary MkPs (black bars) and Day3 MkPs cultivated with a cocktail of
cytokines (grey bars). The y-axis represents enrichment in cDNA sequences normalised to Gapdh gene control sequences. The data show the mean 6
SD of 3 independent experiments. (G) Valproic acid (VPA)-induced differentiation of MKD1 cells. Percentages of CD41
+ (Top left) and CD42b
+ (Top
right) MKD1 cells after 3 days of VPA treatment (25, 50 and 100 mg/ml). The histograms represent the mean 6 SD of 3 independent experiments.
*, p,0.05. (Middle) Facs plots showing the percentage of high CD41 expressing cells before and after VPA treatment (25 and 50 mg/ml). (Bottom)
Ploidy analysis of MKD1 cells after VPA treatment for 7 days. The cells were gated on CD41 high expressing cells. The histograms represent the
percentage of the different class ploidy for each condition (white bars: Epo, IL3, grey bars: Epo, IL3, VPA 25 mg/ml, black bars: Epo, IL3, VPA 50 mg/ml).
The data show the mean 6 SD of 3 independent experiments. *, p,0.002.
doi:10.1371/journal.pone.0032981.g001
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compared to adult bone marrow MKs, such as lower ploidy and
different responsiveness to cytokines: Epo and SCF stimulate the
formation of MK colonies derived from early yolk sac but not
adult bone marrow cells [15]. We propose that an early (yolk sac
type) origin of MKD1 cells could therefore explain why Epo
sustains their growth. Albeit at low levels, the MKD1 clone
expresses the erythroid marker Ter119 (Figure 1C). Therefore, to
be able to distinguish between the primitive versus definitive
nature of the MKD1 cells (corresponding to the first versus second
wave of hematopoiesis in the yolk sac, see [16]), we assessed globin
gene expression (data not shown). Interestingly, the MKD1 cells
did not express embryonic bH1 globin, but we did detect
expression of the adult a and b globin genes. Altogether, these
data suggest that MKD1 cells are likely to represent the second
wave of yolk sac hematopoiesis giving rise to definitive progenitors
[16].
Overall, the cell surface immunophenotype, ploidy and mRNA
content show that MKD1 cells share similarities with MkPs. The
immature phenotype of MKD1 could be explained by two factors.
First, Hox11 enforced expression is indeed associated with
immature phenotypes [5]; second, IL3 is known to promote the
earliest stage of megakaryopoiesis while inhibiting further
maturation after endomitosis begins [17].
We then investigated whether MKD1 cells could further
differentiate along the MK pathway. We did not see any difference
in CD41/CD42 expression and ploidy levels at high concentra-
tions of TPO (100 ng/ml) or phorbol myristic acetate (TPA) (not
shown). In contrast, treatment of MKD1 cells with valproic acid
(VPA), a potent inhibitor of histone deacetylases recently reported
to promote megakaryopoiesis [18–20] increased CD41 and CD42
expression in a dose-dependent manner (Figure 1G, top).
Moreover, the CD41
high cell population (increased by 2 to 4-fold
upon VPA treatment) (Figure 1G, middle) showed a 3-fold
increase in the 8N, 16N and 32N ploidy classes at 25 mg/ml of
VPA (Figure 1G, graphs). Therefore, VPA induces MKD1 cells to
differentiate further along the MK pathway.
To carry functional investigations, we took advantage of the Scl
floxed locus in MKD1 cells and of our recently described MK-
specific Scl
fl/fl mouse model [7] and compared the effects of Scl
excision in MKD1 cells and primary MkPs. Confirming the
critical role of SCL in MK differentiation [21], Cre-mediated
excision of Scl floxed alleles triggered apoptosis in MKD1 cells
(Figure 2A). Similarly to what we observed from Scl-deleted
primary MkPs [7], p21 (cell cycle inhibitor) expression was 1.5-fold
increased in Scl-deleted MKD1 cells (Figure 2B). Likewise, a
dramatic decrease in Gp6 expression was observed from Scl-deleted
MKD1 cells, Scl-deleted MkPs (Figure 2B) and Scl-deleted MKs
[7], suggesting that SCL normally activates Gp6 expression in
immature (MkPs and MKD1) as well as mature megakaryocytes.
As a control, Pf-4 expression is unaltered in Scl
ex/ex MKD1, MkPs
(Figure 2B) and MKs [7]. In conclusion, our data demonstrate that
Scl excision affects gene expression similarly in primary MkPs and
MKD1 cells.
Finally, we analysed SCL-mediated transcriptional regulation of
Gp6 in MKD1 cells. SCL is part of a multiprotein complex
(including E-proteins such as E12, LMO2, LDB1, and GATA1)
that regulates megakaryocytic gene expression [8,22]. Using
chromatin immunoprecipitation (ChIP) assays, all members of
this pentameric complex, as well as FLI1, an important regulator
of megakaryopoiesis [23], were detected on the Gp6 proximal
promoter in MKD1 cells, on sequences containing E-box, GATA,
Sp1 and Ets motifs (Figure 2C, left panel, regions P3 and P4).
Importantly, the same sequences were bound by SCL in primary
MKs (Figure 2C, right panel). In luciferase assays, co-expression of
the SCL complex and FLI1 in 3T3 cells correlated with Gp6
promoter transcriptional activity, while introduction of point
mutations in the E-box, Gata and Ets motifs reduced Gp6
promoter activity in MKD1 cells by 70, 90 and 60% respectively
(Figure 2D), hence establishing the functional activity of this
complex. Therefore, gene expression, ChIP and transcriptional
analyses can be successfully carried out in MKD1 cells, opening
the way to biochemical and functional studies.
To date, only three animal megakaryocytic cell lines have been
reported [24–26]. Here, we describe the mES cell-derived MKD1
clone as a close model of mouse primary MkPs. These cells express
very low levels of Mpl; restoring MPL expression in MKD1 cells
may allow the cells to respond more specifically to TPO signalling
and rescue their differentiation potential (as observed for the
human cell lines UT7 [27] and 32D [28]) and providing an even
more potent model of megakaryopoiesis.
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Figure 2. Functional and transcriptional analyses in MKD1 cells. (A) Scl excision induces apoptosis in MKD1 cells. Annexin V and 7AAD
staining of MKD1 cells (Scl
fl/fl) and upon Cre-mediated excision of the Scl floxed alleles (Scl
ex/ex). (Left) Left panels, FSC and SSC parameters analysis
showing the gate of viable cells. Rights panels, Annexin V/7AAD analysis. The percentages of necrotic (AnnexinV
+ 7AAD
+) and apoptotic cells
(Annexin V
+ 7AAD
2) are shown. The data show one representative experiment out of three. (Right) PCR showing amplification of the floxed (fl) and
excised (D) alleles in MKD1 cells (Scl
fl/fl) and after Cre-mediated excision (Scl
ex/ex). (B) Gene expression analysis by qRT-PCR of MKD1 and MkPs in SCL
expressing cells (dark grey bars: MKD1 Scl
fl/fl, white bars: Cre;Scl
+/+ MkPs) and upon Cre-mediated Scl excision; Scl
ex/ex (black bars: MKD1 Scl
ex/ex; light
grey bars: Cre;Scl
ex/ex MkPs). The y-axis represents the enrichment in cDNA sequences normalised to Gapdh gene control sequences. For MKD1, the
histograms show the mean 6 SD of 3 independent experiments, p,0.05. For the MkPs, the data show one representative experiment out of 2. (C)
(Top) Schematic representation of the mouse Gp6 proximal promoter. The location of the E box (E), Gata (G), Sp1 and Ets motifs is indicated, in bp
relative to the transcription start site (+1). P1 to P4 show the location of the primer pairs designed for real-time PCR. Not to scale. (Bottom) ChIP
analysis over the Gp6 locus using material isolated from MKD1 cells (left) and primary megakaryocytes derived from 5-FU treated mouse (right). The
antibodies used are indicated. The data show the mean 6 SD of 3 independent experiments; enrichment over no antibody, *p,0.05. (D) Trans-
activation assays in 3T3 (left) and MKD1 cells (right). Top, the luciferase gene is under control of a 330 bp fragment of the Gp6 promoter. The reporter
constructs with point mutations in the E box (Emut), Gata (Gatamut) and Ets motifs (Etsmut) are shown below. (Left) The graph shows relative
luciferase activity measured in 3T3 cells transiently transfected with the luciferase reporter construct (GP6-330) and vectors expressing the indicated
transcription factors. The mean 6 SD of four independent experiments performed in duplicate is shown. *, p,0.05. (Right) The graph shows relative
luciferase activity measured in MKD1 cells transiently nucleotransfected with the different luciferase reporter constructs as indicated. The mean 6 SD
of three independent experiments performed in duplicate is shown. *, p,0.05.
doi:10.1371/journal.pone.0032981.g002
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